This article was originally published on June 21, 2022. A former president took a shot at another former president when asked a question on a late-night talk show. What Happened: In a June appearance on “Late Late Show With James Corden,” former President Bill Clinton was a featured guest.
Yesterday, 11:06 AM
Dogecoin (CRYPTO: DOGE) and Shiba Inu’s (CRYPTO: SHIB) popularity skyrocketed beginning in early 2021 in the midst of Bitcoin (CRYPTO: BTC) an
Trump-Linked SPAC Faces Another Setback As Private Investors Withdraw $138.5M Commitment: Is The Deal At Risk?
Yesterday, 9:57 AM
Digital World Acquisition Corp. (NASDAQ: DWAC), the special purpose acquisition company that was set to merge with Donald Trump’s media company behind the Truth Social platform, is struggling to complete the deal and is now facing another setback.
F5 Could More Than Double As Solid Demand Trends Continue & Supply Constrains Start To Ease, Needham Says
September 23, 3:24 PM
Needham analyst Alex Henderson reiterated a Buy and $303 price target on F5, Inc (NASDAQ:FFIV). F5 was careful not to update conditions post…
September 23, 2:47 PM
The SPDR S&P 500 ETF Trust (NYSE: SPY) suffered more heavy losses this week in response to another aggressive Federal Reserve interest rate hike
September 23, 1:03 PM
With food inflation still surging, up 8% for the twelve months ended August, and the Russia-Ukraine war adding to global food constraints, it's easy to see why restaurant brands and operators are experiencing diminishing margins on their bottom line.
September 23, 12:44 PM
Trian Partners was founded in 2005 by activist investor Nelson Peltz, who has a history of buying up shares, securing board seats and orchestrating M&A deals.
September 23, 12:15 PM
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Friday.
Pfizer Resumes Dosing In Phase 3 Hemophilia Gene Therapy Trial Six Months After FDA Lifts Clinical Hold
September 23, 12:02 PM
Pfizer Inc (NASDAQ:PFE) and its partner Sangamo Therapeutics Inc (NASDAQ:SGMO) have reopened enrollment in phase 3 AFFINE study hemophilia A gene therapy trial. …